Oval instruments ease bimanual cataract surgery

Article

Using oval choppers and needles during bimanual cataract surgery spares energy and maintains anterior chamber stability.

Using oval choppers and needles during bimanual cataract surgery spares energy and maintains anterior chamber stability, according to Fernando Araujo-Gomes from the Clinica de Santo Antonio, Amadora, Portugal.

According to Dr Gomes, the advantage of oval-designed instruments is related to their ability to form a closed, energy-sparing, system thus minimising fluid loss and pressure.

A total of 750 consecutive cataracts, both soft and hard, underwent surgery using oval choppers and needles. Depending on the hardness of cataract, 20-gauge (1.4 mm opening) or 21-gauge (1.2 mm opening) were used.

All surgeries were straightforward, quick and effective and maintained good anterior chamber stability.

According to Dr Gomes, there is no need to avoid bimanual cataract surgery, particularly because there are no other types of surgery that will allow surgeons to create a 1.4 mm incision whilst employing a separate irrigation line, which he finds beneficial.

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.